Last reviewed · How we verify
Crataegus Special Extract WS 1442 — Competitive Intelligence Brief
phase 3
Botanical extract / Herbal preparation
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Crataegus Special Extract WS 1442 (Crataegus Special Extract WS 1442) — National Center for Complementary and Integrative Health (NCCIH). Crataegus WS 1442 is a standardized hawthorn extract that improves cardiac function and blood flow by enhancing myocardial contractility and reducing peripheral vascular resistance.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Crataegus Special Extract WS 1442 TARGET | Crataegus Special Extract WS 1442 | National Center for Complementary and Integrative Health (NCCIH) | phase 3 | Botanical extract / Herbal preparation |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Botanical extract / Herbal preparation class)
- National Center for Complementary and Integrative Health (NCCIH) · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Crataegus Special Extract WS 1442 CI watch — RSS
- Crataegus Special Extract WS 1442 CI watch — Atom
- Crataegus Special Extract WS 1442 CI watch — JSON
- Crataegus Special Extract WS 1442 alone — RSS
- Whole Botanical extract / Herbal preparation class — RSS
Cite this brief
Drug Landscape (2026). Crataegus Special Extract WS 1442 — Competitive Intelligence Brief. https://druglandscape.com/ci/crataegus-special-extract-ws-1442. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab